BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2023 9:50:15 AM | Browse: 132 | Download: 344
 |
Received |
|
2022-11-23 19:06 |
|
Peer-Review Started |
|
2022-11-23 19:08 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-01-04 02:29 |
|
Revised |
|
2023-02-10 21:09 |
|
Second Decision |
|
2023-04-07 01:06 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-04-07 06:56 |
|
Articles in Press |
|
2023-04-07 06:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-05-19 00:22 |
|
Publish the Manuscript Online |
|
2023-05-26 09:50 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Post-COVID-19 cholangiopathy: Current understanding and management options
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Fadl H Veerankutty, Kushan Sengupta, Mukul Vij, Ashwin Rammohan, Dinesh Jothimani, Ananthavadivelu Murali and Mohamed Rela |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fadl H Veerankutty, DNB, MBBS, MS, Consultant Physician-Scientist, Surgeon, Institute of Liver Disease and Transplantation, Dr. Rela Institute and Research Centre, 7, CLC Works Rd, Nagappa Nagar, Chromepet, Chennai 600044, India. fadl_05@yahoo.com |
| Key Words |
COVID-19; Liver; Post-COVID-19 syndrome; Long haulers; Cholangiopathy; Cholestasis |
| Core Tip |
Post-coronavirus disease 2019 (COVID-19) cholangiopathy (PCC) is a rare complication of COVID-19 infection with gruesome prognosis. There is no proven treatment for this entity and patients often end up in liver transplantation. This review focusses on pathophysiology, clinical manifestations and management strategies of PCC along with our experience with antiplatelets in managing patients with PCC. |
| Publish Date |
2023-05-26 09:50 |
| Citation |
Veerankutty FH, Sengupta K, Vij M, Rammohan A, Jothimani D, Murali A, Rela M. Post-COVID-19 cholangiopathy: Current understanding and management options. World J Gastrointest Surg 2023; 15(5): 788-798 |
| URL |
https://www.wjgnet.com/1948-9366/full/v15/i5/788.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v15.i5.788 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
